BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2799626)

  • 1. [Radiotherapy technics and results in nasopharyngeal carcinoma at the Cologne University Clinics from 1974 to 1985].
    Roth SL; Sack H; Bertram G
    Strahlenther Onkol; 1989 Sep; 165(9):633-40. PubMed ID: 2799626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 10-year survival rate for patient with nasopharyngeal carcinoma after radiation therapy. Clinical analysis of 367 cases.
    Chen CQ; Liu TF; Zhao S
    Chin Med J (Engl); 1989 Apr; 102(4):239-42. PubMed ID: 2507236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary radiotherapy of nasopharyngeal carcinoma].
    Rübe C; Grevers G; Grimminger H; Wendt T; Rohloff R
    Laryngorhinootologie; 1995 Feb; 74(2):103-7. PubMed ID: 7710601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiotherapy of 100 cancers of the cavum].
    Baillet F; Simon JM; Rozec C; Ronchin P; Salemkour M; Dessard-Diana B; Diana C; Housset M
    Bull Cancer Radiother; 1996; 83(2):70-4. PubMed ID: 8688221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
    Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
    Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiotherapy of nasopharyngeal carcinoma].
    Oguchi M; Kiyono K; Watanabe T; Sone S; Imai Y; Kawai T; Takei K; Maruyama K; Maruyama Y
    Gan No Rinsho; 1987 Oct; 33(12):1407-13. PubMed ID: 3682192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reirradiation for locally recurrent nasopharyngeal carcinoma: treatment results and prognostic factors.
    Oksüz DC; Meral G; Uzel O; Cağatay P; Turkan S
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):388-94. PubMed ID: 15380570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of prognostic factors in 106 cases of carcinoma of the rhinopharynx treated with cobalt teletherapy].
    Zini G; Alberti G; Armaroli L; Barbieri E; Di Marzio G; Frezza G; Neri S; Silvano M; Babini L
    Radiol Med; 1989 Nov; 78(5):430-4. PubMed ID: 2608930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lymphoepithelial carcinoma of the nasopharynx: the treatment results following radiotherapy].
    Leicher-Düber A; Düber C; Kutzner J; Thelen M
    Strahlenther Onkol; 1986 Nov; 162(11):698-703. PubMed ID: 3787454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiotherapy in the treatment of tumors of the nasopharynx in advanced stage].
    Donato V; Maurizi Enrici R; Banelli E; Cerqua M; Falchetto Osti M; Santarelli M; Vitturini A
    Radiol Med; 1990 Oct; 80(4):506-9. PubMed ID: 2244040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy.
    Shen C; Lu JJ; Gu Y; Zhu G; Hu C; He S
    Laryngoscope; 2008 Jul; 118(7):1206-10. PubMed ID: 18418278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
    Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
    Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasopharyngeal cancer in the Middle East: experience of the American University of Beirut Medical Center.
    Geara FB; Nasr E; Tucker SL; Brihi E; Zaytoun G; Hadi U; Salem Z; El Saghir N; Issa P; Shamseddine A
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1408-15. PubMed ID: 15817344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of brachytherapy and fractionated stereotactic radiotherapy boost for persistent nasopharyngeal carcinoma.
    Yau TK; Sze WM; Lee WM; Yeung MW; Leung KC; Hung WM; Chan WI
    Head Neck; 2004 Dec; 26(12):1024-30. PubMed ID: 15390194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasopharyngeal carcinoma with cranial nerve palsy: the importance of MRI for radiotherapy.
    Chang JT; Lin CY; Chen TM; Kang CJ; Ng SH; Chen IH; Wang HM; Cheng AJ; Liao CT
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1354-60. PubMed ID: 16297716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of radiation therapy of nasopharyngeal cancer].
    Watanabe H; Gomi H; Yamanashi S; Takayama M; Sugimoto T; Kanehira C; Yamashita T; Gomi M; Mochizuki S
    Gan No Rinsho; 1986 Jan; 32(1):17-22. PubMed ID: 3081745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of dose boost in skull base on recurrence of stage T4 nasopharyngeal carcinoma].
    Xie GF; Cao KJ; Li Y; Huang PY
    Ai Zheng; 2005 Oct; 24(10):1246-8. PubMed ID: 16219141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of failure following radiation with and without chemotherapy in patients with nasopharyngeal carcinoma.
    Fuchs S; Rödel C; Brunner T; Iro H; Niedobitek G; Sauer R; Grabenbauer GG
    Onkologie; 2003 Feb; 26(1):12-8. PubMed ID: 12624512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG).
    Teo PM; Leung SF; Tung SY; Zee B; Sham JS; Lee AW; Lau WH; Kwan WH; Leung TW; Chua D; Sze WM; Au JS; Yu KH; O SK; Kwong D; Yau TK; Law SC; Sze WK; Au G; Chan AT
    Radiother Oncol; 2006 Apr; 79(1):27-33. PubMed ID: 16626829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.